Ocrelizumab for multiple sclerosis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of ocrelizumab in people with relapsing‐remitting multiple sclerosis (RRMS) or primary progressive multiple sclerosis (PPMS).

Saved in:
Bibliographic Details
Published in:Cochrane Database Syst Rev
Main Authors: Lin, Mengbing, Shi, Shengliang, Zhang, Jian, Yang, Cheng Min, Luo, Jiefeng
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Ltd 2019
Subjects:
Medicine General & Introductory Medical Sciences
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353045/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013247
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items